Suchen
Tonix Pharmaceuticals Holding Corp
TNXPZur Watchlist hinzufügen
11.870USD
-0.410-3.34%
Handelsschluss 09-11 16:00（ET）
198.99MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Tonix Pharmaceuticals Holding Corp Unternehmen
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Tonix Pharmaceuticals Holding Corp Profil
BörsenkürzelTNXP
Name des UnternehmensTonix Pharmaceuticals Holding Corp
IPO-datumMar 29, 2010
CEOLederman (Seth)
Anzahl der mitarbeiter81
WertpapierartOrdinary Share
GeschäftsjahresendeMar 29
Addresse26 Main Street, Suite 101
StadtCHATHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07928
Telefon12129809155
Websitehttps://www.tonixpharma.com/
BörsenkürzelTNXP
IPO-datumMar 29, 2010
CEOLederman (Seth)
Führungskräfte von Tonix Pharmaceuticals Holding Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Dr. Gregory M. (Greg) Sullivan, M.D.
Dr. Gregory M. (Greg) Sullivan, M.D.
Secretary
Secretary
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Tonix Pharmaceuticals Holding Corp?
Die fünf größten Anteilseigner von Tonix Pharmaceuticals Holding Corp sind: Dr. Seth Lederman, M.D.
Wie viele Institutionen halten Anteile an Tonix Pharmaceuticals Holding Corp (TNXP)?
Mit Stand vom 2026Q1 halten 177 Institutionen Anteile an Tonix Pharmaceuticals Holding Corp, mit einem Gesamtmarktwert von etwa 4.66M, was 32.65% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 2019652.00 gestiegen.